No impact on our client’s Fitness to Practise
It was a difficult case which involved untested guidelines written prior to the advent of online services and social media.
This case involved a number of regulatory bodies and various departments within them. We were approached at a very early stage, which allowed us to devise a strategy to minimise damage very early and address with insight and remediation, but also refuse to accept others. It was a difficult case which involved untested guidelines written prior to the advent of online services and social media. We construct robust submissions and the matter was all dealt with at the earliest stage with no impact on our client’s fitness to practise.
Fitness to practise defence barrister, Stephen McCaffrey, said:
“Once again, the case demonstrates the need to take a sensible approach based on early advice and a clear agreed strategy. This case was a little unconventional but these principles applied just the same.”
Our client said:
“Very happen with the services and outcome. The case when along the route as expected and explained by the team. Couldn’t recommend enough. This should be your first and last point of call.”
Disclaimer: This article is for guidance purposes only. Kings View Chambers accepts no responsibility or liability whatsoever for any action taken, or not taken, in relation to this article. You should seek the appropriate legal advice having regard to your own particular circumstances.
More News & Articles
Understanding disproportionate fitness to practise referrals: why doctors must act early to protect their careers
Disproportionate fitness to practise referrals to the GMC continue to affect doctors from minority ethnic backgrounds and those who qualified outside the UK.
Pharmacy business owner avoids GPhC fitness to practise hearing
A long‑running GPhC investigation into historic governance and management concerns has concluded with no referral to a fitness to practise hearing.
Kings View Chambers wins case against GPhC request for removal
A pharmacist facing serious regulatory action in the online pharmacy sector has avoided removal from the register.

